Drug-Eluting Stents Market Size, Share and Forecast Report 2022-2027 by Kanika Sharma

Global Drug-Eluting Stents Market Research Report 2022-2027

About IMARC Group

Report Description

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights Report Description Global Drug-Eluting Stents Market Outlook 2022-2027: According to the latest report by IMARC Group, titled "Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global drug-eluting stents market reached a value of US$ 7.3 Billion in 2021. Drug-eluting stents refer to coronary or peripheral tools that are widely used in the treatment of blockage of heart arteries. These stents are generally placed within the coronary or peripheral artery by an interventional radiologist or cardiologist during an angioplasty procedure. They are small mesh tubes that are generally manufactured using metal or polymers and coated with slow-release medication that is inserted into an artery for preventing the formation of scar tissues in arterial walls. As a result, they ensure adequate blood flow to the body while minimizing the chance of restenosis. Request for a PDF sample of this report: https://www.imarcgroup.com/drug-eluting-stents-market/requestsample

Report Description and Highlights

Report Description

Global Drug-Eluting Stents Market Drivers/Constraints: The global market is primarily driven by the rising prevalence of coronary heart diseases among the masses. This is supported by the sedentary lifestyle patterns and unhealthy dietary habits of individuals. Since drug-eluting stents are minimally invasive in nature, facilitate fast vessel healing and reduce the need for prolonged dual antiplatelet therapy, this is providing a boost to the market growth. Additionally, continual product innovations, such as the utilization of antiproliferative drugs in the stent in order to reduce the chance of in-stent restenosis, are gaining widespread prominence. In line with this, the introduction of drug-eluting stents manufactured using bioabsorbable polymers due to an enhanced focus on sustainable development is creating a positive outlook for the market. Moreover, increasing investments by private and public agencies in upgrading the existing healthcare infrastructure are also propelling the market growth. Other factors, including the rising geriatric population, the growing healthcare expenditure, and extensive research and development (R&D) activities conducted by key players, are further contributing to the market growth. Looking forward, the market is anticipated to reach a value of US$ 10.8 Billion by 2027, growing at a CAGR of 6.50% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/drug-eluting-stents-market

Report Description and Highlights

Report Description Key Market Segmentation

The research report includes the following segments:

Breakup by Coating: •Polymer Based Coating •Polymer Free Coating

Breakup by Drug: •Sirolimus •Paclitaxel •Zotarolimus •Everolimus •Biolimus •Others

Report Description and Highlights

Report Description Breakup by Stent Platform: •Stainless-steel •Cobalt-Chromium •Platinum-Chromium •Nitinol •Others

Breakup by Generation: •1st Generation •2nd Generation •3rd Generation •4th Generation

Breakup by Application: •Coronary Artery Disease •Peripheral Artery Disease

Report Description and Highlights

Report Description Breakup by End User:

•Hospitals •Ambulatory Surgical Centers •Others

Breakup by Region: •North America (United States, Canada) •Europe (Germany, France, United Kingdom, Italy, Spain, Others) •Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others) •Latin America (Brazil, Mexico, Others) •Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others) Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click here: https://www.imarcgroup.com/request?type=report&id=4815&flag=E

Report Description and Highlights

Report Description Competitive Landscape: • • • • • • • • • • • •

Abbott Laboratories B. Braun Melsungen AG Biosensors International Group Ltd. Biotronik Boston Scientific Corporation Cardinal Health Inc. Cook Medical LLC (Cook Group Incorporated) Lepu Medical Technology (Beijing) Co. Ltd. Medtronic plc MicroPort Scientific Corporation Sino Medical Sciences Technology Inc. Terumo Corporation.

Key Questions Answered in the Report

Report Description

Key Questions Answered in This Report:

•How has the global drug-eluting stents market performed so far and how will it perform in the coming years? •What has been the impact of COVID-19 on the global drug-eluting stents market? •What are the key regional markets? •What is the breakup of the market based on the coating? •What is the breakup of the market based on the drug? •What is the breakup of the market based on the stent platform? •What is the breakup of the market based on the generation? •What is the breakup of the market based on the application? •What is the breakup of the market based on the end user? •What are the various stages in the value chain of the industry? •What are the key driving factors and challenges in the industry? •What is the structure of the global drug-eluting stents market and who are the key players? •What is the degree of competition in the industry?

Report Description 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology

3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends

Table of Contents

Report Description

Table of Contents

5 Global Drug-Eluting Stents Market 5.1 5.2 5.3 5.4

Market Overview Market Performance Impact of COVID-19 Market Forecast

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

© 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com